Home › Companies › VENTYX BIOSCIENCES INC. › 2024-2025

VENTYX BIOSCIENCES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and VENTYX BIOSCIENCES INC.’s Form 8-K, filed 2025-06-10 (Item 5.07 on EDGAR). Page generated 02 October 2026.

4Ballot items
119Asset managers
518Fund votes
2025-06-04Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore VENTYX BIOSCIENCES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by VENTYX BIOSCIENCES INC.

These tallies are VENTYX BIOSCIENCES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-06-10 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

VENTYX BIOSCIENCES INC. — official shareholder meeting results, meeting held 2025-06-04
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Somasundaram Subramaniam, M.B.A.	17,175,776	--	--	14,517,133	17,997,451	Majority: yes
Elect Director: Sheila Gujrathi, M.D.	29,409,104	--	--	2,283,805	17,997,451	Majority: yes
Proposal 2: Advisory Vote on Executive Compensation.	20,421,575	10,900,876	370,458	--	17,997,451	Majority: yes
Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm.	47,804,128	1,580,619	305,614	--	--	Majority: yes

Source: VENTYX BIOSCIENCES INC., Form 8-K, filed with the SEC on 2025-06-10 — read the filing on EDGAR.

How asset managers voted at the VENTYX BIOSCIENCES INC. 2024-2025 meeting

Each item below shows how the 119 asset managers that disclosed a VENTYX BIOSCIENCES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote").

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

65% Majority: yes · of votes cast

FOR 65%AGAINST 35%

FOR: 20,421,575AGAINST: 10,900,876

VENTYX BIOSCIENCES INC.’s own tally for this item (“Proposal 2: Advisory Vote on Executive Compensation.”): 20,421,575 for, 10,900,876 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,499,332 outstanding shares: 29% for, 15% against (44% of the company cast a for/against vote).

The 118 asset managers below cast 57% of the shares they voted on this item FOR (13,938,586 for, 10,400,067 against).

FOR 57%AGAINST 43%

FOR: 13,938,586 (57.3%)AGAINST: 10,400,067 (42.7%)

Largest asset managers voting on “To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summ” at VENTYX BIOSCIENCES INC., 2024-2025
Asset manager	For	Against	Vote
Vanguard	3,520,066	25,315	For
BlackRock	2,843,625	428	For
Point72	0	1,765,617	Against
Vestal Point Capital, LP	0	1,679,999	Against
GEODE CAPITAL MANAGEMENT, LLC	1,497,970	0	For
Fidelity	1,354,981	0	For
Redmile Group, LLC	0	1,297,042	Against
State Street	1,021,964	11,599	For
Charles Schwab	0	901,970	Against
Connor, Clark & Lunn Investment Management Ltd.	0	753,891	Against
JPMorgan	645,378	0	For
Citadel	590,324	0	For
AQR	0	566,612	Against
Affinity Asset Advisors, LLC	485,649	0	For
Northern Trust	447,088	8,289	For
Delaware/Macquarie	0	430,000	Against
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST	0	430,000	Against
Qiming U.S. Ventures Management, LLC	412,225	0	For
TCG Crossover Management, LLC	316,195	0	For
ADAR1 Capital Management, LLC	0	281,600	Against
CIBC WORLD MARKET INC.	0	272,500	Against
MELLON INVESTMENTS Corp	225,147	0	For
Graham Capital Management, L.P.	0	224,008	Against
Invesco	0	217,662	Against
Equitable	214,130	0	For

Showing the 25 largest of 118 asset managers. See all 118 in the interactive database.

2. To elect two Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Sheila Gujrathi, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%7%

FOR: 29,409,104WITHHELD: 2,283,805

VENTYX BIOSCIENCES INC.’s own tally for this item (“Elect Director: Sheila Gujrathi, M.D.”): 29,409,104 for, 2,283,805 withheld, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,499,332 outstanding shares: 42% for, 3% withheld (45% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (7,523,121 for, 0 against).

FOR 98%

FOR: 7,523,121 (97.7%)ABSTAIN: 175,421 (2.3%)

Largest asset managers voting on “To elect two Class I directors to hold office until our 2028 annual meeting of stockholders and until their re” at VENTYX BIOSCIENCES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	3,475,555	0	For
Fidelity	1,340,055	0	For
BlackRock	968,864	0	For
Charles Schwab	450,985	0	For
Delaware/Macquarie	430,000	0	For
Equitable	214,130	0	For
TIAA	132,656	0	For
Lincoln Financial	56,668	49,206	For
Invesco	98,897	0	For
Voya	0	65,470	Abstain
AQR	42,693	0	For
BRIDGEWAY FUNDS INC	39,000	0	For
Global X	36,018	0	For
Dimensional	0	31,088	Abstain
AIG/SunAmerica	29,774	0	For
Northern Trust	28,505	0	For
Pacific Life	28,016	0	For
Bridge Builder Trust	26,957	0	For
John Hancock	24,081	0	For
State Street	0	21,167	Abstain
Brighthouse	17,537	0	For
Nationwide	16,546	0	For
Goldman Sachs	15,753	0	For
ProShares	12,282	0	For
DWS	9,709	0	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

3. To elect two Class I directors to hold office until our 2028 annual meeting of stockholders and until their respective successors are elected and qualified: Somasundaram Subramaniam, M.B.A.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

54.2% Majority: yes · of votes cast

FOR 54.2%WITHHELD 45.8%

FOR: 17,175,776WITHHELD: 14,517,133

VENTYX BIOSCIENCES INC.’s own tally for this item (“Elect Director: Somasundaram Subramaniam, M.B.A.”): 17,175,776 for, 14,517,133 withheld, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,499,332 outstanding shares: 24% for, 21% withheld (45% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (4,949,829 for, 0 against).

FOR 64%ABSTAIN 36%

FOR: 4,949,829 (64.3%)ABSTAIN: 2,748,713 (35.7%)

Largest asset managers voting on “To elect two Class I directors to hold office until our 2028 annual meeting of stockholders and until their re” at VENTYX BIOSCIENCES INC., 2024-2025
Asset manager	For	Abstain	Vote
Vanguard	3,475,555	0	For
Fidelity	1,340,055	0	For
BlackRock	0	968,864	Abstain
Charles Schwab	0	450,985	Abstain
Delaware/Macquarie	0	430,000	Abstain
Equitable	0	214,130	Abstain
TIAA	0	132,656	Abstain
Lincoln Financial	104,868	1,006	For
Invesco	0	98,897	Abstain
Voya	0	65,470	Abstain
AQR	0	42,693	Abstain
BRIDGEWAY FUNDS INC	0	39,000	Abstain
Global X	0	36,018	Abstain
Dimensional	0	31,088	Abstain
AIG/SunAmerica	0	29,774	Abstain
Northern Trust	0	28,505	Abstain
Pacific Life	0	28,016	Abstain
Bridge Builder Trust	0	26,957	Abstain
John Hancock	0	24,081	Abstain
State Street	21,167	0	For
Brighthouse	0	17,537	Abstain
Nationwide	0	16,546	Abstain
Goldman Sachs	0	15,753	Abstain
ProShares	0	12,282	Abstain
DWS	0	9,709	Abstain

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

4. TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

97% Majority: yes · of votes cast

FOR 97%

FOR: 47,804,128AGAINST: 1,580,619

VENTYX BIOSCIENCES INC.’s own tally for this item (“Proposal 3: Ratification of Appointment of Independent Registered Public Accounting Firm.”): 47,804,128 for, 1,580,619 against, per its Form 8-K filed 2025-06-10 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 70,499,332 outstanding shares: 68% for, 2% against (70% of the company cast a for/against vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (7,698,542 for, 0 against).

FOR 100%

FOR: 7,698,542 (100.0%)

Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FI” at VENTYX BIOSCIENCES INC., 2024-2025
Asset manager	For	Vote
Vanguard	3,475,555	For
Fidelity	1,340,055	For
BlackRock	968,864	For
Charles Schwab	450,985	For
Delaware/Macquarie	430,000	For
Equitable	214,130	For
TIAA	132,656	For
Lincoln Financial	105,874	For
Invesco	98,897	For
Voya	65,470	For
AQR	42,693	For
BRIDGEWAY FUNDS INC	39,000	For
Global X	36,018	For
Dimensional	31,088	For
AIG/SunAmerica	29,774	For
Northern Trust	28,505	For
Pacific Life	28,016	For
Bridge Builder Trust	26,957	For
John Hancock	24,081	For
State Street	21,167	For
Brighthouse	17,537	For
Nationwide	16,546	For
Goldman Sachs	15,753	For
ProShares	12,282	For
DWS	9,709	For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

Largest VENTYX BIOSCIENCES INC. shareholders voting in 2024-2025

Ranked by the number of VENTYX BIOSCIENCES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 70,499,332 shares outstanding at the time of that meeting.

Top VENTYX BIOSCIENCES INC. shareholders by shares voted, 2024-2025
#	Asset manager	% of shares outstanding
1	Vanguard	5.03%
2	BlackRock	4.03%
3	Point72	2.50%
4	Vestal Point Capital, LP	2.38%
5	GEODE CAPITAL MANAGEMENT, LLC	2.12%
6	Fidelity	1.92%
7	Redmile Group, LLC	1.84%
8	State Street	1.47%
9	Charles Schwab	1.28%
10	Connor, Clark & Lunn Investment Management Ltd.	1.07%

Reported VENTYX BIOSCIENCES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

VENTYX BIOSCIENCES INC. beneficial owners on record for the 2024-2025 proxy season
Holder	% outstanding	Disclosure
Somasundaram Subramaniam	7.70%	13D
BlackRock	6.30%	13F
Entities affiliated with Point72 Asset Management, L.P.	6.24%	DEF14A
Raju Mohan	6.22%	13D
Entities affiliated with Citadel Advisors LLC	6.07%	DEF14A
Point72	6.01%	13F
Affinity Healthcare Fund, LP	5.75%	13G
Entities affiliated with New Science Ventures	5.72%	DEF14A
Vanguard Group	4.98%	13F
Geode Capital	2.08%	13F

Percentages above are of 70,499,332 shares outstanding, as reported by VENTYX BIOSCIENCES INC. on its Form 10-Q dated 2024-05-06 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VENTYX BIOSCIENCES INC.’s 10-Q dated 2024-05-06. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At VENTYX BIOSCIENCES INC.'s shareholder meeting held 2025-06-04, in the 2024-2025 proxy season, 119 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 518 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the named executive officers identified… — FOR was 65% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: VENTYX BIOSCIENCES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-06-10.

VENTYX BIOSCIENCES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.